The Journal of Practical Medicine >
Protective role of intestinal microbial network in hyperoxaluria⁃induced kidney impairment in rats
Received date: 2023-07-12
Online published: 2024-07-09
Objective To explore the effects of fecal microbiota transplantation (FMT) on oxalate metabolism and renal protection in rats fed a high oxalate diet. Methods Twenty-four male SD rats were randomly divided into four groups: SC, SC + FMT, OD + PBS and OD + FMT. The SC group was set as the control group and was fed standard rat chow. The OD + PBS group and OD + FMT group were fed a diet containing 5% oxalate. Starting from day 14, the OD + PBS group, OD + FMT group and SC + FMT group received intragastric administration of PBS solution or filtered faecal microbiota solution from guinea pigs for 7 consecutive days. The 24-hour urine, feces, and venous serum of the rats were collected from the rats of all groups to determine the gut microbiota and biochemical markers. Real-time quantitative PCR and immunohistochemistry were conducted on the rat kidneys to detect the expression of renin, ACE, and OPN. Results The fecal microbiota transplantation altered the gut microbiota of rats. The gut microbiota of the SC + FMT group deviated from that of the SC group and showed increased similarity to that of the guinea pigs. Compared to the OD + PBS group, the OD + FMT group exhibited significant reductions in the urinary oxalate, urinary urea, uric acid, urinary creatinine, serum urea nitrogen/creatinine, and serum uric acid. Furthermore, after FMT treatment, the OD + FMT group exhibited reduced upregulation of renin mRNA expression and restored downregulation of OPN mRNA expression compared to the OD + PBS group; similar results were obtained from immunohistochemistry. Conclusion Fecal microbiome trans-plantation activated the microbial network in the rat gut, particularly the oxalate-degrading bacteria represented by Muribaculaceae. The kidney injury induced by high oxalate was partially restored by the microbiota network's degradation of oxalate, indicating the protective effect of fecal microbiota transplantation on the rat kidneys.
Yan WANG , Tiejun PAN , Zhenyu LIU , Jinbo SUN , Yu ZHOU , Chaosheng LI , Lei. GAO . Protective role of intestinal microbial network in hyperoxaluria⁃induced kidney impairment in rats[J]. The Journal of Practical Medicine, 2024 , 40(13) : 1771 -1777 . DOI: 10.3969/j.issn.1006-5725.2024.13.002
| 1 | 吴志良. 不同手术方式治疗男性复杂性肾结石的疗效和对患者性功能影响的比较[J]. 实用医学杂志, 2018,34(20):3449-3453. doi:10.3969/j.issn.1006-5725.2018.20.030 |
| 2 | XU L, ADAMS-HUET B, POINDEXTER J R, et al. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation[J]. J Urol, 2017,197(6):1465-1471. doi:10.1016/j.juro.2017.01.057 |
| 3 | LIESKE J C, PE?A DE LA VEGA L S, SLEZAK J M, et al. Renal stone epidemiology in Rochester, Minnesota: An update[J]. Kidney Int, 2006,69(4):760-764. doi:10.1038/sj.ki.5000150 |
| 4 | CIL O, CHU T, LEE S, et al. Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis[J]. JCI Insight, 2022,7(13):e153359. doi:10.1172/jci.insight.153359 |
| 5 | CANALES B K, HATCH M. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies[J]. Surg Obes Relat Dis, 2014,10(4):734-742. doi:10.1016/j.soard.2014.03.026 |
| 6 | HOLMES R P, KNIGHT J, ASSIMOS D G. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease[J]. Urolithiasis, 2016,44(1):27-32. doi:10.1007/s00240-015-0839-4 |
| 7 | MITCHELL T, KUMAR P, REDDY T, et al. Dietary oxalate and kidney stone formation[J]. Am J Physiol Renal Physiol, 2019,316(3): F409-F413. doi:10.1152/ajprenal.00373.2018 |
| 8 | TURRONI S, BENDAZZOLI C, DIPALO S C F, et al. Oxalate-Degrading Activity inBifidobacterium animalis subsp.lactis: Impact of Acidic Conditions on the Transcriptional Levels of the Oxalyl Coenzyme A (CoA) Decarboxylase and Formyl-CoA Transferase Genes[J]. Appl Environ Microbiol, 2010,76(16):5609-5620. doi:10.1128/aem.00844-10 |
| 9 | MOGNA L, PANE M, NICOLA S, et al. Screening of Different Probiotic Strains for Their In Vitro Ability to Metabolise Oxalates: Any Prospective Use in Humans? [J]. J Clin Gastroenterol, 2014,48(Supp1):S91-S95. doi:10.1097/mcg.0000000000000228 |
| 10 | KAUFMAN D W, KELLY J P, CURHAN G C, et al. Oxalobacter formigenes May Reduce the Risk of Calcium Oxalate Kidney Stones[J]. J Am Soc Nephrol, 2008,19(6):1197-1203. doi:10.1681/asn.2007101058 |
| 11 | STERN J M, MOAZAMI S, QIU Y, et al. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers[J]. Urolithiasis, 2016,44(5):399-407. doi:10.1007/s00240-016-0882-9 |
| 12 | TICINESI A, MILANI C, GUERRA A, et al. Understanding the gut–kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers[J]. Gut, 2018,67(12):2097-2106. doi:10.1136/gutjnl-2017-315734 |
| 13 | TAVASOLI S, ALEBOUYEH M, NAJI M, et al. Association of intestinal oxalate‐degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case–control study[J]. BJU Int, 2020,125(1):133-143. doi:10.1111/bju.14840 |
| 14 | CHEN F, BAO X, LIU S, et al. Gut microbiota affect the formation of calcium oxalate renal calculi caused by high daily tea consumption[J]. Appl Microbiol Biotechnol, 2021,105(2):789-802. doi:10.1007/s00253-020-11086-w |
| 15 | GOLDFARB D S, MODERSITZKI F, ASPLIN J R. A Randomized, Controlled Trial of Lactic Acid Bacteria for Idiopathic Hyperoxaluria[J]. Clin J Am Soc Nephrol, 2007,2(4):745-749. doi:10.2215/cjn.00600207 |
| 16 | HOPPE B, GROOTHOFF J W, HULTON S, et al. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria[J]. Nephrol Dial Transplant, 2011,26(11):3609-3615. doi:10.1093/ndt/gfr107 |
| 17 | SIENER R, BADE D J, HESSE A, et al. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria[J]. J Transl Med, 2013,11:306. doi:10.1186/1479-5876-11-306 |
| 18 | HOPPE B, NIAUDET P, SALOMON R, et al. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria[J]. Pediatr Nephrol, 2017,32(5):781-790. doi:10.1007/s00467-016-3553-8 |
| 19 | MILLINER D, HOPPE B, GROOTHOFF J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria[J].Urolithiasis, 2018,46(4):313-323. doi:10.1007/s00240-017-0998-6 |
| 20 | MILLER A W, OAKESON K F, DALE C, et al. Microbial Community Transplant Results in Increased and Long-Term Oxalate Degradation[J]. Microb Ecol, 2016,72(2):470-478. doi:10.1007/s00248-016-0800-2 |
| 21 | MILLER A W, DALE C, DEARING M D. The Induction of Oxalate Metabolism In Vivo Is More Effective with Functional Microbial Communities than with Functional Microbial Species[J]. mSystems, 2017,2(5):e00088-17. doi:10.1128/msystems.00088-17 |
| 22 | SIDHU H, ALLISON M J, CHOW J O M, et al. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes[J]. J Urol, 2001,166(4):1487-1491. doi:10.1016/s0022-5347(05)65817-x |
| 23 | SALAZAR N, DE LOS REYES-GAVILáN C G. Editorial: Insights into Microbe-Microbe Interactions in Human Microbial Ecosystems: Strategies to Be Competitive[J]. Front Microbiol, 2016,7:1508. doi:10.3389/fmicb.2016.01508 |
| 24 | GREEN J E, DAVIS J A, BERK M, et al. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis[J]. Gut Microbes, 2020,12(1):1-25. doi:10.1080/19490976.2020.1854640 |
| 25 | STERN J M, URBAN-MALDONADO M, USYK M, et al. Fecal transplant modifies urine chemistry risk factors for urinary stone disease[J]. Physiol Rep, 2019,7(4):e14012. doi:10.14814/phy2.14012 |
| 26 | MILLER A W, CHOY D, PENNISTON K L, et al. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis[J]. Kidney Int, 2019,96(1):180-188. doi:10.1016/j.kint.2019.02.012 |
| 27 | 张建清, 王庆, 江克华, 等. microRNA在肾结石疾病中的作用机制和研究进展[J]. 实用医学杂志, 2023,39(6):773-777. doi:10.3969/j.issn.1006-5725.2023.06.021 |
/
| 〈 |
|
〉 |